(MGK) Mega Cap Growth Shares - Overview
Etf: Large-Cap Stocks, Growth Stocks, US Equities, Index Tracking, Mega-Cap
Dividends
| Dividend Yield | 0.38% |
| Yield on Cost 5y | 0.69% |
| Yield CAGR 5y | 7.66% |
| Payout Consistency | 97.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.1% |
| Relative Tail Risk | 5.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | -5.10 |
| Character TTM | |
|---|---|
| Beta | 1.194 |
| Beta Downside | 1.147 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.36% |
| CAGR/Max DD | 1.18 |
Description: MGK Mega Cap Growth Shares December 17, 2025
The Vanguard Mega Cap Growth Index Fund ETF (MGK) uses a passive, float-adjusted market-cap weighting to mirror the performance of the U.S. mega-cap growth segment, holding each constituent in roughly the same proportion as the index and investing virtually all of its assets in those stocks. Because it focuses on a relatively narrow slice of the market, the fund is classified as non-diversified.
Key data points as of the latest reporting period: the fund’s expense ratio is 0.07 %, markedly lower than the average for large-growth ETFs (≈0.20 %); total assets under management exceed $70 billion, reflecting strong investor demand for low-cost growth exposure. The top sector allocations are technology (≈45 %), consumer discretionary (≈20 %), and healthcare (≈15 %). Recent macro-economic drivers-particularly the Federal Reserve’s stance on interest rates-have a outsized impact on growth valuations, making the fund’s performance sensitive to changes in monetary policy and earnings growth expectations.
For a deeper, data-driven breakdown of MGK’s risk-adjusted returns and sector dynamics, you might explore the analytics platform ValueRay.
What is the price of MGK shares?
Over the past week, the price has changed by -3.08%, over one month by -4.82%, over three months by -3.88% and over the past year by +11.87%.
Is MGK a buy, sell or hold?
What are the forecasts/targets for the MGK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 471.9 | 20% |
MGK Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 31.45b USD (31.45b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 31.45b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 31.45b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.32% (E(31.45b)/V(31.45b) * Re(10.32%) + (debt-free company))
Discount Rate = 10.32% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)